1h Free Analyst Time
The Chemical, Biological, Radiological & Nuclear Security Market is projected to reach USD 19.94 Billion in 2026. It is expected to continue growing at a CAGR of 7.55%, reaching USD 30.95 Billion by 2032. Speak directly to the analyst to clarify any post sales queries you may have.
Chemical, Biological, Radiological and Nuclear security has moved from a specialist defense function to a whole-of-society resilience priority spanning chemical security, biosecurity, radiological source security, nuclear security, border control, public health preparedness, critical infrastructure protection and emergency consequence management. The operating environment is shaped by two simultaneous realities: strong treaty architecture and rising operational complexity. The Chemical Weapons Convention has 193 States Parties, and the OPCW has verified the destruction of all declared chemical weapons stockpiles, totaling 72,304 metric tons; at the same time, the Biological Weapons Convention has 189 States Parties, the Nuclear Non-Proliferation Treaty has 191 parties, and WHO’s International Health Regulations are legally binding on 196 countries.
For industry leaders, the core challenge is no longer limited to compliance with CBRN regulations; it is the integration of intelligence-led prevention, rapid detection, secure supply chains, trained response teams, interoperable data systems and trusted public communication. The IAEA’s Incident and Trafficking Database remains a key indicator of persistent radiological and nuclear security risk because it tracks illicit trafficking, theft, loss, unauthorized acquisition and discovery of uncontrolled nuclear or radioactive material reported by participating states.
The executive implication is clear: CBRN security programs must be designed as adaptive risk systems. Organizations that handle hazardous chemicals, biological materials, radioactive sources, nuclear technologies, emergency medical countermeasures, detection equipment or critical infrastructure should align governance, training, procurement, cyber resilience and incident response under a unified CBRN risk management model.
Transformative Shifts in CBRN Risk
The CBRN security landscape is being transformed by geopolitical instability, dual-use technology diffusion, weakened arms-control confidence and a broader understanding of deliberate, accidental and naturally occurring hazards. SIPRI’s Yearbook 2026 reported that the nine nuclear-armed states continued to modernize and enhance their nuclear arsenals in 2025, with an estimated 12,187 nuclear warheads globally in January 2026, including about 9,745 in military stockpiles, 4,012 deployed with missiles and aircraft, and between 2,100 and 2,200 kept on high operational alert.Chemical security has shifted from declared stockpile destruction toward preventing re-emergence, detecting toxic industrial chemical misuse, securing precursor supply chains and strengthening national implementing legislation. Biological security has expanded beyond traditional pathogen control into genomic data governance, laboratory biosafety, synthetic biology oversight, medical countermeasure readiness and cross-border surveillance. WHO’s IHR framework requires countries to prevent, detect, assess, report and respond to public health risks with international implications, making biosurveillance and public health emergency preparedness central to CBRN resilience.
Radiological and nuclear security is increasingly focused on material control outside high-security nuclear complexes, including transport security, source recovery, port-of-entry detection, insider-threat management and nuclear forensics. The IAEA ITDB’s scope includes unauthorized acquisition, theft, possession, transfer, disposal, loss and discovery of uncontrolled material, which underscores why radiological dispersal risk and source security remain operational priorities for hospitals, industrial users, research institutions and logistics networks.
Artificial Intelligence as a CBRN Force Multiplier
Artificial intelligence is becoming a cumulative force multiplier across CBRN security because it can improve detection, modeling, triage, logistics and decision support while also creating dual-use risks in chemistry, biology and cyber-physical systems. The U.S. Department of Homeland Security’s AI and CBRN assessment warned that AI could help improve CBRN prevention, detection, response and mitigation, but also lower barriers for harmful chemical and biological experimentation when combined with accessible data, lab automation or weak oversight.In biological security, the highest-impact AI issue is the convergence of generative models, protein design, genomic data and synthetic nucleic acid ordering. NIST has emphasized that organizations performing nucleic acid synthesis need guidance to identify and mitigate AI-related risks, and it launched work with the Engineering Biology Research Consortium to develop screening and safety tools for synthetic biology.
For CBRN industry leaders, AI should be adopted with a controls-first mindset: validated models, secure training data, human-in-the-loop review, red-team testing, audit logs, procurement controls, incident escalation protocols and safeguards against model misuse. AI can strengthen plume modeling, anomaly detection, radiological mapping, syndromic surveillance and emergency logistics, but only when paired with responsible AI governance, cybersecurity and domain-expert verification.
Regional CBRN Security Insights
Asia-Pacific is a high-priority CBRN security region because it combines nuclear-armed states, advanced civil nuclear programs, dense maritime trade, large chemical manufacturing ecosystems, major biotechnology capabilities and disaster-prone urban corridors. ASEAN’s regional CBR network was created to strengthen cooperation against chemical, biological and radiological threats, while the EU CBRN Centres of Excellence identify Southeast Asia partner countries including Brunei Darussalam, Cambodia, Indonesia, Lao PDR, Malaysia, Myanmar, the Philippines, Singapore, Thailand and Viet Nam.North America remains one of the most capability-rich CBRN security environments, anchored by mature defense programs, public health institutions, nuclear regulation, WMD law enforcement and advanced detection infrastructure. The United States has institutionalized CBRN and WMD prevention across agencies, while Canada contributes to allied interoperability, border security and global threat reduction; Mexico’s strategic importance is tied to border management, industrial chemical safety and public health surveillance across a large trade corridor.
Latin America’s CBRN priorities center on radiological source security, major-event preparedness, public health capacity, chemical supply-chain oversight and customs enforcement. The region benefits from the nuclear-weapon-free-zone norm established by the Treaty of Tlatelolco, and the IAEA highlights regulatory infrastructure development projects in the Caribbean and Latin America for radiation safety and nuclear security.
Europe is advancing CBRN preparedness through NATO deterrence and defense, EU civil protection, rescEU stockpiles and external risk-mitigation partnerships. NATO’s CBRN policy requires Allies to maintain military capabilities and national resilience, while rescEU includes medical and CBRN strategic stockpiles, emergency medical capabilities and equipment for chemical, biological, radiological and nuclear emergencies.
The Middle East faces a complex CBRN risk picture shaped by conflict exposure, critical energy infrastructure, industrial chemical risk, missile and drone threats, nuclear security concerns and emergency management requirements. The EU CBRN CoE network includes dedicated Middle East and Gulf Cooperation Council regional engagement, reflecting regional emphasis on preparedness, response coordination and protection of critical infrastructure.
Africa’s CBRN security agenda is increasingly focused on chemical safety legislation, public health surveillance, radiological source control, border security and capacity building. OPCW’s Africa Programme, launched in 2007, supports Chemical Weapons Convention implementation, chemical safety, chemical security and development, while EU CBRN CoE regional engagement covers African Atlantic, Eastern and Central Africa, and North Africa and Sahel partner countries.
Group-Level CBRN Security Insights
ASEAN’s CBRN profile is defined by regional capability building, counterterrorism preparedness, emergency response coordination and the need to secure high-volume trade routes. The ASEAN Chemical, Biological and Radiological Defence Experts network functions as a regional node for information sharing, best practices and technical cooperation, strengthening collective preparedness across Southeast Asia.The GCC is a critical CBRN security grouping because of its energy infrastructure, desalination dependence, cross-border logistics, chemical industry footprint and proximity to regional conflict risks. The EU CBRN CoE identifies the GCC regional partner countries as Saudi Arabia, Bahrain, Kuwait, Qatar, Oman and the United Arab Emirates, indicating a structured platform for regional CBRN risk mitigation and preparedness cooperation.
The European Union is one of the most systematized civilian CBRN security actors. Its CBRN Centres of Excellence initiative covers 64 partner countries across eight regions, with 104 implemented projects, 19 ongoing projects, 36 completed national action plans, 15 ongoing national action plans and more than 750 experts cooperating through the network.
BRICS brings together countries with major industrial, nuclear, biotechnology, public health and security capabilities, making it relevant to CBRN governance even where members differ politically. Its practical CBRN relevance lies in counterterrorism coordination, export-control alignment, emergency preparedness, public health capacity and dual-use technology governance across large populations and strategic supply chains.
The G7 remains a central driver of global CBRN threat reduction through the Global Partnership Against the Spread of Weapons and Materials of Mass Destruction, a 31-member initiative focused on preventing state and non-state proliferation and mitigating chemical, biological, radiological and nuclear threats.
NATO’s CBRN role is anchored in deterrence, defense, resilience and interoperability. Its 2022 CBRN Defence Policy commits Allies to integrated CBRN military capabilities, national resilience, exercises, training, equipment, planning and recovery capacity, making NATO a benchmark for multi-domain CBRN preparedness.
Country-Level CBRN Security Insights
The United States leads with large-scale WMD prevention, chemical and biological defense modernization, nuclear security, emergency response and public health preparedness. The Department of Defense’s 2024 Chemical and Biological Defense Program Enterprise Strategy prioritizes operationally relevant capabilities at speed and scale and calls for stronger integration with allies, interagency partners, industry and academia. Canada is positioned as a strong allied CBRN partner through nuclear safety institutions, border security, emergency management and global threat reduction cooperation, while Mexico’s priorities include hazardous material transport, port and border screening, public health surveillance and industrial chemical governance.Brazil anchors Latin American CBRN preparedness through its civil nuclear expertise, major industrial base, health security responsibilities and regional leadership role. In Europe, the United Kingdom, Germany, France, Italy and Spain combine NATO or EU frameworks with national civil protection, defense, public health and critical infrastructure programs; France and the United Kingdom also remain NPT-recognized nuclear-weapon states, and SIPRI reported ongoing modernization among all nine nuclear-armed states in 2025. Germany, Italy and Spain are especially relevant for CBRN consequence management, medical preparedness, industrial chemical safety and EU stockpile coordination.
Russia remains central to global CBRN risk analysis because of its large nuclear arsenal, strategic competition with NATO and the importance of arms-control transparency. China is a priority CBRN country because of its expanding nuclear capabilities, major chemical and biotechnology sectors, and civil nuclear development. India combines nuclear deterrence, high biotechnology capacity, major chemical manufacturing and public health preparedness needs; Japan and South Korea are advanced technology and civil defense leaders with strong roles in radiological monitoring, industrial safety, biosurveillance and alliance interoperability. Australia is strategically important because of its Indo-Pacific security partnerships, biosecurity controls, nuclear submarine pathway under AUKUS and disaster response capacity.
Actionable Priorities for CBRN Leaders
Industry leaders should begin by establishing a unified CBRN governance model that connects safety, security, cyber, legal, operations, procurement, human resources and communications. The most resilient organizations treat chemical inventories, biological materials, radioactive sources, nuclear-relevant technologies, AI tools and emergency response assets as part of one risk register rather than separate compliance silos.Priority actions include conducting CBRN threat and vulnerability assessments, validating material accounting, strengthening access controls, screening suppliers, hardening transport protocols, training personnel on suspicious activity indicators, integrating detection data with emergency operations centers and aligning exercises with local public health, law enforcement and emergency management partners. This is consistent with NATO’s emphasis on military capability, national resilience, training, equipment, plans and exercises, and with WHO’s IHR focus on prevention, detection, reporting and response.
Leaders should also build AI governance into CBRN programs now. That means requiring model risk assessments, misuse testing, data provenance controls, secure laboratory informatics, biosynthesis screening, incident reporting pathways and human review for high-consequence decisions. NIST’s work on AI-related synthetic biology safeguards shows that responsible AI adoption is becoming a core component of biosecurity and broader CBRN risk management.
Research Methodology
This executive summary was developed through a source-led methodology using authoritative public-domain references from international organizations, government agencies and recognized security institutions. Core sources included OPCW data on Chemical Weapons Convention implementation and verified stockpile destruction; UNODA information on the Biological Weapons Convention and Nuclear Non-Proliferation Treaty; WHO guidance on the International Health Regulations; IAEA information on the Incident and Trafficking Database; SIPRI Yearbook 2026 findings on nuclear forces; NATO CBRN Defence Policy; EU rescEU and EU CBRN Centres of Excellence materials; NIST AI biosecurity guidance; and U.S. defense releases on chemical and biological defense modernization.The analysis prioritized verified institutional data, treaty participation, official policy frameworks, public safety mandates, capacity-building initiatives and current risk indicators. It intentionally excludes market estimation, market sizing, market share and market forecasting. Insights were synthesized qualitatively to support executive decision-making and web readability while avoiding operationally sensitive or harmful technical instructions.
Conclusion
CBRN security is entering a period where preparedness must be faster, more integrated and more technologically literate. Treaty regimes remain indispensable, but the practical burden has shifted toward implementation: secure facilities, trained personnel, reliable detection, resilient health systems, protected supply chains, credible response plans and responsible AI governance.The strongest organizations will be those that can connect chemical safety, biosecurity, radiological source control, nuclear security, cyber resilience and emergency management into one intelligence-led operating model. As nuclear modernization, synthetic biology, AI-enabled research and cross-border instability reshape the risk environment, CBRN security leaders should invest in prevention, interoperability and trust before an incident occurs. The strategic objective is not only to respond to CBRN events, but to reduce the probability, severity and societal disruption of chemical, biological, radiological and nuclear threats.
Additional Product Information:
- Purchase of this report includes 1 year online access with quarterly updates.
- This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.
Table of Contents
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
7. Chemical, Biological, Radiological & Nuclear Security Market, by Product Type
8. Chemical, Biological, Radiological & Nuclear Security Market, by Technology
9. Chemical, Biological, Radiological & Nuclear Security Market, by Deployment Mode
10. Chemical, Biological, Radiological & Nuclear Security Market, by Service
11. Chemical, Biological, Radiological & Nuclear Security Market, by Application
13. Europe Chemical, Biological, Radiological & Nuclear Security Market
14. North America Chemical, Biological, Radiological & Nuclear Security Market
15. Latin America Chemical, Biological, Radiological & Nuclear Security Market
16. Africa Chemical, Biological, Radiological & Nuclear Security Market
17. Middle East Chemical, Biological, Radiological & Nuclear Security Market
18. NATO Chemical, Biological, Radiological & Nuclear Security Market
19. G7 Chemical, Biological, Radiological & Nuclear Security Market
20. European Union Chemical, Biological, Radiological & Nuclear Security Market
21. BRICS Chemical, Biological, Radiological & Nuclear Security Market
22. ASEAN Chemical, Biological, Radiological & Nuclear Security Market
23. GCC Chemical, Biological, Radiological & Nuclear Security Market
24. United States Chemical, Biological, Radiological & Nuclear Security Market
25. China Chemical, Biological, Radiological & Nuclear Security Market
26. Germany Chemical, Biological, Radiological & Nuclear Security Market
27. Japan Chemical, Biological, Radiological & Nuclear Security Market
28. India Chemical, Biological, Radiological & Nuclear Security Market
29. United Kingdom Chemical, Biological, Radiological & Nuclear Security Market
30. France Chemical, Biological, Radiological & Nuclear Security Market
31. Canada Chemical, Biological, Radiological & Nuclear Security Market
32. Italy Chemical, Biological, Radiological & Nuclear Security Market
33. Australia Chemical, Biological, Radiological & Nuclear Security Market
34. South Korea Chemical, Biological, Radiological & Nuclear Security Market
35. Brazil Chemical, Biological, Radiological & Nuclear Security Market
36. Mexico Chemical, Biological, Radiological & Nuclear Security Market
37. Russia Chemical, Biological, Radiological & Nuclear Security Market
38. Spain Chemical, Biological, Radiological & Nuclear Security Market
39. Competitive Landscape
40. Company Profiles
List of Figures
List of Tables
Companies Mentioned
The companies featured in this Chemical, Biological, Radiological & Nuclear Security market report include:- Airbus SE
- Ansell Limited
- Argon Electronics Ltd.
- Avon Technologies Plc
- BAE Systems plc
- Bertin Technologies SAS
- BioFire Defense, LLC by bioMérieux
- Blücher GmbH
- Bruker Corporation
- Chemring Group plc
- Cristanini S.P.A.
- Drägerwerk AG & Co. KGaA
- Emergent BioSolutions Inc.
- Honeywell International Inc.
- Krauss-Maffei Wegmann GmbH & Co. KG
- Kromek Group plc
- Leonardo S.p.A.
- Mirion Technologies Inc.
- Proengin SA
- QinetiQ Group plc
- Raytheon Technologies Corporation
- Smiths Group plc
- Teledyne FLIR LLC
- Thales Group
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 196 |
| Published | June 2026 |
| Forecast Period | 2026 - 2032 |
| Estimated Market Value ( USD | $ 19.94 Billion |
| Forecasted Market Value ( USD | $ 30.95 Billion |
| Compound Annual Growth Rate | 7.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 24 |
